Illumina, Inc. Stock price

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
130.1 USD +1.89% Intraday chart for Illumina, Inc. -6.41% -6.54%
Sales 2024 * 4.52B Sales 2025 * 4.99B Capitalization 20.3B
Net income 2024 * -140M Net income 2025 * 185M EV / Sales 2024 * 4.5 x
Net Debt 2024 * 23.7M Net cash position 2025 * 882M EV / Sales 2025 * 3.89 x
P/E ratio 2024 *
-174 x
P/E ratio 2025 *
92.4 x
Employees 10,615
Yield 2024 *
-
Yield 2025 *
-
Free-Float 79.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.89%
1 week-3.91%
Current month-6.93%
1 month-9.25%
3 months+2.39%
6 months-10.95%
Current year-6.54%
More quotes
1 week
125.82
Extreme 125.82
138.94
1 month
125.82
Extreme 125.82
146.08
Current year
125.82
Extreme 125.82
148.19
1 year
89.00
Extreme 89
233.42
3 years
89.00
Extreme 89
526.00
5 years
89.00
Extreme 89
555.77
10 years
89.00
Extreme 89
555.77
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 23-09-24
Director of Finance/CFO 52 19-09-22
Chief Tech/Sci/R&D Officer - 97-12-31
Members of the board TitleAgeSince
Director/Board Member 69 12-11-28
Chairman 60 23-06-01
Director/Board Member 64 17-01-26
More insiders
Date Price Change Volume
24-03-18 130.1 +1.89% 2,846,620
24-03-15 127.7 -0.29% 2,239,647
24-03-14 128.1 -3.52% 1,437,785
24-03-13 132.8 +0.05% 1,590,013
24-03-12 132.7 -4.57% 2,134,263

Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
130.1 USD
Average target price
159.7 USD
Spread / Average Target
+22.74%
Consensus
  1. Stock
  2. Equities
  3. Stock Illumina, Inc. - Nasdaq